Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 5, 2025Neuro-Oncology

Ep18.01 Global Collaboration to Support the Translation of Brain Tumour Therapies: Early Impact and Learnings From a Novel Therapeutics Accelerator.

View Full Paper
Ask AI
Bookmark
Share

Authors

CACharlotte AitkenKBK. BushbyCGCamille Goetz

Discussion

Loading...

Member takes

Overview

A new therapeutics accelerator improves clinical trial design and multidisciplinary input for brain tumour therapies.

Key Points

  • The BTR-NTA has received 29 requests for support from global researchers developing new brain tumour therapies.
  • Eleven therapies have undergone comprehensive review, supported by 37 multidisciplinary experts providing input.
  • Participants reported a 100% intention to refine research and development strategies based on BTR-NTA guidance.
  • The programme highlights recurring translational challenges to assist the broader neuro-oncology community.

Cite This Study

Aitken et al. (2025) studied this question.

synapsesocial.com/papers/68e24e6bd6d66a53c2473acchttps://doi.org/10.1093/neuonc/noaf193.648
View Full Paper
Ask AI
Bookmark
Share